Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study

PURPOSE: To evaluate the blood pressure (BP) lowering efficacy and safety of CKD-828, a fixed-dose combination of S-amlodipine (the more active isomer of amlodipine besylate, which is calcium channel blocker) and telmisartan (long acting angiotensin receptor blocker), in patients with hypertension i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ihm, Sang-Hyun, Jeon, Hui-Kyung, Cha, Tae-Joon, Hong, Taek-Jong, Kim, Sang-Hyun, Lee, Nae-Hee, Yoon, Jung Han, Yoon, Namsik, Hwang, Kyung-Kuk, Jo, Sang-Ho, Youn, Ho-Joong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125808/
https://www.ncbi.nlm.nih.gov/pubmed/27920497
http://dx.doi.org/10.2147/DDDT.S116847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125808/
https://www.ncbi.nlm.nih.gov/pubmed/27920497
http://dx.doi.org/10.2147/DDDT.S116847

Ejemplares similares